Complex Disease Genetics
The Components of GP2’s 8th Data Release
Learn MoreOverviewIn September 2024, GP2 announced the eighth data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release i…
The Components of GP2’s Seventh Data Release
Learn MoreOverviewIn April 2024, GP2 announced the seventh data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release incl…
The Components of GP2’s Sixth Data Release
Learn MoreOverviewIn December 2023, GP2 announced the sixth data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release inc…
Spotlight: Introducing the new GP2 Cohort Browser Application
Learn MoreThe Terra cloud platform allows you to do analysis directly on the cloud, removing the need to download GP2 data directly to your personal computer. This blog …
The Components of GP2’s Fifth Data Release
Learn MoreThis release includes 7,462 additional new complex disease participants and 487 new monogenic disease participants, adding to the previous releases from the Co…
The Components of GP2’s Third Data Release
Learn MoreIn October 2022, GP2 announced the third data release on the Terra platform in collaboration with AMP® PD. This release is packed full of new data and resource…
Introduction to Using Workspaces and GP2 Data
Learn MoreThe Terra cloud platform allows you to do analysis directly on the cloud, removing the need to download GP2 data directly to your personal computer. This blog …
The Components of GP2’s Second Data Release
Learn MoreIn April 2022, GP2 announced the second data release on the Terra platform in collaboration with AMP® PD. This release contains data from both complex and mono…
Surgicogenomics and Individuals with GBA Mutations
Learn MoreBenjamin Stecher and Alfonso Fasano discuss how using genetic information as a prognostic indicator might be relevant to assess surgical outcomes.
The Components of GP2’s First Data Release
Learn MoreLearn more about the process to gather genotype and clinical data as well as the different tiers of data access available.
Building Clinical and Genetic Data for GP2 in the Cohort Integration Working Group
Learn MoreHuw Morris leads the Cohort Integration working group (CIWG). In this blog post, Huw provides an outline of the research on Parkinson’s disease over the last 2…
Understanding GWAS: Part 2 – Additional Insights and Tips
Learn MoreAs a follow-up to the last blog post on Understanding GWAS, the GP2 Complex Disease Data Analysis Working Group has provided practical tips and insights for ru…
Understanding GWAS
Learn MoreMembers of the GP2 Complex Disease Data Analysis working group provide an overview of Genome-Wide Association Studies (GWAS), including statistical formulae, w…
Why study disease in different populations?
Learn MoreGP2 aims to revolutionize our understanding of the genetics of Parkinson's disease across populations. Ignacio 'Nacho' Mata explains the importance of involvin…
